亚太改良德尔菲共识会议:大肝细胞癌
亚太地区31位专家采用改良德尔菲法(三轮匿名调查加讨论小组)就大肝细胞癌(结节≥5 cm)的定义与优化管理达成共识。共识推荐对无血管侵犯或肿瘤播散的孤立性大肝细胞癌采用独立的BCLC分期系统,并指出门静脉癌栓是重要预后因素。
要点
- 大肝细胞癌定义为结节直径≥5 cm。
- 孤立性大肝细胞癌(无血管侵犯或播散)推荐采用独立的BCLC分期系统。
- 门静脉癌栓是重要预后因素,诊断可依据多期增强CT/MRI及AFP≥400。
核心结论
- 量身定制手术方式、确保准备充分并优化资源是成功管理单发大肝细胞癌的关键。
- 该共识旨在指导外科医生,尤其在亚太地区。
研究设计与样本
- 亚太共识会议采用改良德尔菲法,包括三轮调查和随后的小组讨论。
- 31位专家匿名贡献意见以完善陈述并达成关于大肝细胞癌的共识。
关键影像表现/征象
- 大肝细胞癌定义为结节测量≥5 cm。
- 孤立性大肝细胞癌(无血管侵犯或肿瘤播散)肝切除后显示更长的生存期和更低的复发率。
- 门静脉癌栓是关键预后因素。
诊断标准与关键数值
- 大肝细胞癌定义为结节≥5 cm。
- 推荐对无血管侵犯或肿瘤播散的孤立性大肝细胞癌采用独立的BCLC分期系统。
- 孤立性大肝细胞癌诊断可依据多期对比增强放射学(CT/MRI)和AFP水平≥400。
- 术前肝功能评估在无肝脏体积测定时指导切除规划。
临床应用与阅片要点
- 大肝细胞癌行大范围肝切除和腹腔镜入路是可行的。
- 术后放射学监测至关重要。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Approximately 80 % of primary liver cancer cases happen in Asia-Pacific and become the leading cause of cancer-related mortality. However, there is no consensus on defining and standardizing the optimal management of large HCCs.
METHODS: The Asia-Pacific Consensus Conference employed the Modified Delphi method, consisting of three rounds of surveys followed by a discussion panel. In this process, 31 experts anonymously contributed their opinions to refine statements and achieve a consensus on large HCC.
RESULTS: A large hepatocellular carcinoma (HCC) is a nodule measuring ≥5 cm. A distinct BCLC staging system is recommended for solitary large HCC (SLHCC) without vascular invasion or tumor dissemination, as these cases show prolonged survival and lower recurrence rates post-liver resection. Portal vein tumor thrombosis (PVTT) is a crucial prognostic factor. Diagnosis of SLHCC can rely on multiphasic contrast-enhancing radiology (CT/MRI) and AFP levels ≥400. Preoperative liver function assessments guide resection planning where liver volumetry is unavailable. Major hepatectomy and laparoscopic approaches are viable for SLHCC, and postoperative radiological surveillance is essential.
CONCLUSION: Tailoring surgical approaches, ensuring readiness, and optimizing resources are key to successful single large HCC management. This consensus aims to guide surgeons, especially in the Asia-Pacific region.
引用
- Nugroho A, Lalisang AN, Lalisang TJM, et al. Asia-Pacific modified Delphi consensus conference on large hepatocellular carcinoma. HPB (Oxford). 2025. PMID: 40796407. doi:10.1016/j.hpb.2025.07.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。